Literature DB >> 22200864

A TASH experience: post-infarction myocardial oedema necessitating the support of ECMO and occurrence of significant mitral regurgitation.

D Basic, H Möllmann, M A Haas, A Rolf, A Jovanovic, Christoph Liebetrau, Sebastian Szardien, J Leick, Oliver Dörr, A Skwara, T Walther, C W Hamm, H M Nef.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22200864     DOI： 10.1007/s00392-011-0396-y

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  17 in total

Review 1.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.

Authors:  Barry J Maron; William J McKenna; Gordon K Danielson; Lukas J Kappenberger; Horst J Kuhn; Christine E Seidman; Pravin M Shah; William H Spencer; Paolo Spirito; Folkert J Ten Cate; E Douglas Wigle
Journal:  J Am Coll Cardiol       Date:  2003-11-05       Impact factor: 24.094

2.  Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy.

Authors:  Shikhar Agarwal; E Murat Tuzcu; Milind Y Desai; Nicholas Smedira; Harry M Lever; Bruce W Lytle; Samir R Kapadia
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

Review 3.  Extracorporeal life support: history and new directions.

Authors:  Robert H Bartlett
Journal:  ASAIO J       Date:  2005 Sep-Oct       Impact factor: 2.872

Review 4.  Management of symptoms in hypertrophic cardiomyopathy.

Authors:  Michael A Fifer; Gus J Vlahakes
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

Review 5.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

6.  Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.

Authors:  U Sigwart
Journal:  Lancet       Date:  1995-07-22       Impact factor: 79.321

7.  Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy.

Authors:  Su Min Chang; Sherif F Nagueh; William H Spencer; Nasser M Lakkis
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

8.  Serial evaluations of myocardial infarct size after alcohol septal ablation in hypertrophic cardiomyopathy and effects of the changes on clinical status and left ventricular outflow pressure gradients.

Authors:  Raed A Aqel; Fadi G Hage; Gilbert J Zohgbi; Paul B Tabereaux; David Lawson; Jaekyeong Heo; Gilbert Perry; Andrew E Epstein; Louis J Dell' Italia; Ami E Iskandrian
Journal:  Am J Cardiol       Date:  2008-03-10       Impact factor: 2.778

Review 9.  The "1st septal unit" in hypertrophic obstructive cardiomyopathy: a newly recognized anatomo-functional entity, identified during recent alcohol septal ablation experience.

Authors:  Paolo Angelini
Journal:  Tex Heart Inst J       Date:  2007

Review 10.  Hypertrophic cardiomyopathy.

Authors:  Perry Elliott; William J McKenna
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321
View more
  4 in total

1.  Percutaneous circulatory support in a patient with cardiac arrest due to acute pulmonary embolism.

Authors:  Jürgen Leick; Christoph Liebetrau; Sebastian Szardien; Matthias Willmer; Johannes Rixe; Holger Nef; Andreas Rolf; Christian Hamm; Helge Möllmann
Journal:  Clin Res Cardiol       Date:  2012-06-12       Impact factor: 5.460

2.  Alcohol septal ablation - an evolving procedure.

Authors:  Ajay Bahl
Journal:  Indian Heart J       Date:  2012-10-29

3.  Door-to-implantation time of extracorporeal life support systems predicts mortality in patients with out-of-hospital cardiac arrest.

Authors:  Jürgen Leick; Christoph Liebetrau; Sebastian Szardien; Ulrich Fischer-Rasokat; Matthias Willmer; Arnaud van Linden; Johannes Blumenstein; Holger Nef; Andreas Rolf; Matthias Arlt; Thomas Walther; Christian Hamm; Helge Möllmann
Journal:  Clin Res Cardiol       Date:  2013-05-09       Impact factor: 5.460

Review 4.  Review of Contemporary Invasive Treatment Approaches and Critical Appraisal of Guidelines on Hypertrophic Obstructive Cardiomyopathy: State-of-the-Art Review.

Authors:  Steven Lebowitz; Mariusz Kowalewski; Giuseppe Maria Raffa; Danny Chu; Matteo Greco; Caterina Gandolfo; Carmelo Mignosa; Roberto Lorusso; Piotr Suwalski; Michele Pilato
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.